These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Combination of 5-flucytosine and capsule-binding monoclonal antibody in the treatment of murine Cryptococcus neoformans infections and in vitro. Feldmesser M, Mukherjee J, Casadevall A. J Antimicrob Chemother; 1996 Mar; 37(3):617-22. PubMed ID: 9182119 [Abstract] [Full Text] [Related]
7. Glyphosate inhibits melanization of Cryptococcus neoformans and prolongs survival of mice after systemic infection. Nosanchuk JD, Ovalle R, Casadevall A. J Infect Dis; 2001 Apr 01; 183(7):1093-9. PubMed ID: 11237835 [Abstract] [Full Text] [Related]
10. Depletion of murine CD8+ T cells in vivo decreases pulmonary clearance of a moderately virulent strain of Cryptococcus neoformans. Mody CH, Chen GH, Jackson C, Curtis JL, Toews GB. J Lab Clin Med; 1993 Jun 01; 121(6):765-73. PubMed ID: 7685044 [Abstract] [Full Text] [Related]
14. Natural cellular resistance of beige mice against Cryptococcus neoformans. Hidore MR, Murphy JW. J Immunol; 1986 Dec 01; 137(11):3624-31. PubMed ID: 3537121 [Abstract] [Full Text] [Related]
15. Contribution of interferon-gamma in protecting mice during pulmonary and disseminated infection with Cryptococcus neoformans. Kawakami K, Tohyama M, Teruya K, Kudeken N, Xie Q, Saito A. FEMS Immunol Med Microbiol; 1996 Feb 01; 13(2):123-30. PubMed ID: 8731020 [Abstract] [Full Text] [Related]
18. Anti-glucuronoxylomannan IgG1 specific antibodies production in Cryptococcus neoformans resistant mice. Parra C, González JM, Castañeda E, Fiorentino S. Biomedica; 2005 Mar 01; 25(1):110-9. PubMed ID: 15962907 [Abstract] [Full Text] [Related]